Mesh Bio

Private

SingaporeHealthcare & Life Scienceshttps://www.meshbio.com/

Last Round

Series A

Jan 30, 2024

Total Funding Raised

$5.3M

Company Overview

Mesh Bio is a health technology company that provides a multidimensional health intelligence platform designed to transform chronic disease management through predictive analytics.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Medical AI, Precision Medicine, Medical Devices, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Data as a Service

AI Layer

Application

Keywords

chronic disease managementpredictive analyticsdigital twinclinical decision supportmedical AISoftware as a Medical DeviceSaMDhealth intelligence platformpatient risk stratificationdigital healthhealthcare analyticsmetabolic digital twinprecision medicineclinical workflow automationB2B healthcare SaaSmulti-omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mesh Bio Comps

Public and private peers based on sector, stage, and business model.

Mesh Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mesh Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jan 30, 2024
Seed	Mar 10, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Arsen Batagov

Co-Founder And CTO

Founding Team

Andrew Wu

Co-Founder And CEO

Founding Team

Adrian CHUA

Chief Operating Officer

Executive Team

Mesh Bio Investors

Notable investors and investment history

Mesh Bio investors
Investor	Rounds
SEEDS Capital	Series A, Seed
East Ventures	Series A
TAEL Partners	Seed
Elev8.vc	Series A, Seed
Citrine Capital Sdn Bhd	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 2, 2026
Monthly visitors increased 117% MoM, reaching 18.9K.
Nov 11, 2025
Monthly visitors increased 1065% MoM, reaching 22K.

View all signals

Mesh Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Mesh Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mesh Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore

Employee Range28

Year Founded2018

Last FundingJan 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.